Clinical Trials Logo

Hyperventilation clinical trials

View clinical trials related to Hyperventilation.

Filter by:

NCT ID: NCT05100290 Completed - Clinical trials for Hyperventilation Syndrome

Predictive Properties of the Hyperventilation Provocation Test for the Diagnosis of the Hyperventilation Syndrome

Start date: June 15, 2018
Phase:
Study type: Observational

The Hyperventilation Provocation Test (HPTest) associated with end-tidal CO2 pressure (PETCO2) measurement is a diagnostic tool for idiopathic hyperventilation syndrome (HVS). However, interpretation of HPTest remains unclear regarding the relevant PETCO2 values to consider and the occurrence of subjective symptoms. This case-control study aims to identify accurate HPTest measurements for the diagnosis of HVS, regardless of symptoms occurrence.

NCT ID: NCT05025332 Recruiting - Clinical trials for Pitt Hopkins Syndrome

An Open-Label Study of Oral NNZ-2591 in Pitt Hopkins Syndrome (PTHS-001)

PTHS-001
Start date: October 14, 2022
Phase: Phase 2
Study type: Interventional

A study of the safety, tolerability and pharmacokinetics of NNZ-2591 and measures of efficacy in children and adolescents with Pitt Hopkins Syndrome.

NCT ID: NCT04974060 Recruiting - Clinical trials for Traumatic Brain Injury

Treatment of Spontaneous Hyperventilation With Remifentanil in Traumatic Brain Injury Patients

Start date: June 1, 2021
Phase: N/A
Study type: Interventional

Spontaneous hyperventilation is common in severe traumatic brain injury patients and correlates closely with poor outcomes. How to treat this pathological condition remain unsolved. Remifentanil is a frequently used short-acting opioid, has the potent side-effect of dose-dependent respiratory inhibition. Specifically, it prolongs the expiratory time only and does not influence the respiratory drive. Among the safety range, the investigators will determine an ideal dose of remifentanil to maintain PaCO2 between 35 to 45 mmHg. The investigators will monitor the cerebral blood flow of the middle cerebral artery and the internal carotid artery to validate cerebral perfusion improvement.

NCT ID: NCT04940273 Recruiting - Clinical trials for Aneurysmal Subarachnoid Hemorrhage

Drug Intervention of Spontaneous Hyperventilation in Patients With Aneurysmal Subarachnoid Hemorrhage

Start date: June 1, 2021
Phase: N/A
Study type: Interventional

Although spontaneous hyperventilation patients with aneurysmal subarachnoid hemorrhage closely associated with poor outcomes, the standard therapy remains unavailable. Remifentanil has the pharmacological characterization of respiratory inhibition, mainly prolonging the expiratory time and decreasing the respiratory rate while preserving the respiratory drive. The investigators hypothesis that spontaneous hyperventilation could be corrected by titrating the dose of remifentanil and cerebral blood flow will augment during this process.

NCT ID: NCT04668638 Recruiting - Clinical trials for Hyperventilation Syndrome

Impact of Respiratory Rehabilitation on Quality of Life in Patients With Hyperventilation Syndrome

RESPIR-HVS
Start date: March 10, 2021
Phase: N/A
Study type: Interventional

The hyperventilation syndrome is a quite frequent pathology, affecting up to 10% of the general population and 40% of the asthmatic population. Its physiopathology is still badly known and even if it is a benign affection, its associated comorbidities and symptomatology greatly decrease the patients' quality of life. Yet, no medicinal treatments have been proved useful, but prescribers noticed improvements after physiotherapy. Given that the physiotherapy impact on hyperventilation syndrome is not well described in the literature, this study aims to scientifically ascertain physiotherapy benefits on quality of life and symptomatology in hyperventilation syndrome-suffering patients.

NCT ID: NCT04514887 Completed - Clinical trials for Laparoscopic Gastric Sleeve Surgery

Mild Intraoperative Hyperventilation to Decrease Post-op. Shoulder Pain After LSG

Start date: June 16, 2019
Phase: N/A
Study type: Interventional

Shoulder pain is common after laparoscopic surgeries. multiple maneuvers are in use to decrease its incidence with variable results. This study aims to investigate the effect of mild hyperventilation to an End-tidal CO2 level of 30-32 mmHg on the occurrence of postoperative shoulder pain. This is carried out through a comparison of the incidence of postoperative shoulder pain an intervention group to that in a control one with a normal End Tidal CO2 35-40 mmHg). controlling for all other variables.

NCT ID: NCT04254952 Completed - Clinical trials for Hyperventilation Syndrome

Turkish Version of Nijmegen Questionnaire

Start date: September 15, 2019
Phase:
Study type: Observational

The study aims to provide Turkish version of Nijmegen Questionnaire for the evaluation of respiratory dysfunction in asthmatic subjects. The incidence of hyperventilation syndrome in asthmatic patients can be determined with the results of the study.

NCT ID: NCT04232059 Completed - Craniotomy Clinical Trials

The Effect of Different Ventilation Strategies on Cerebral Oxygenation Using Near Infrared Spectroscopy (NIRS) in Pediatrics Undergoing Posterior Fossa Tumor Surgery

Start date: January 1, 2020
Phase: N/A
Study type: Interventional

The aim of this study is to evaluate the changes of cerebral oxygen saturation during hyperventilation and normo-ventilation (using near-infrared spectroscopy) in pediatrics undergoing posterior fossa tumor resection.

NCT ID: NCT04132427 Completed - Clinical trials for Pitt Hopkins Syndrome

MTT for Children With Both Pitt Hopkins Syndrome and Gastrointestinal Disorders

Start date: September 30, 2019
Phase: Phase 2
Study type: Interventional

The investigators propose to investigate Microbiota Transfer Therapy (MTT) for treating patients with Pitt Hopkins Syndrome (PTHS) and gastrointestinal problems similar to Irritable Bowel Syndrome (IBS). MTT involves a combination of 10 days of oral vancomycin (an antibiotic to kill pathogenic bacteria), followed by a bowel cleanse, followed by 12 weeks of Fecal Microbiota (FM).

NCT ID: NCT04098731 Completed - Fibromyalgia Clinical Trials

Evaluation of Respiratory Function in Fibromyalgia

Start date: June 28, 2018
Phase:
Study type: Observational

This study will evaluate respiratory function in people with fibromyalgia and whether or not breathing patterns in this patient group can be explained by stress, emotional or biomechanical variables. In addition, examine the relationship between physical ability and lactate values.